AFP and hepatocellular carcinoma: We also observed that PIVKA-II-negative patients tended to have smaller tumor diameters compared to AFP-negative HCC patients, consistent with the findings of Nakamura et al.[32] This suggests that PIVKA-II may be more useful for diagnosing HCC in cases of large tumors compared to AFP, but less effective for small tumors.